James L Wade

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Norman Wolmark, Scott M Lippman, S. Reis, 2006, JAMA.

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

Thomas J. Smith, D Andrew Loblaw, Thomas J Smith, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Thomas J. Smith, Gary H Lyman, Thomas J Smith, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.